A glycoprotein pharmaceutical whose clearance is controlled by the content of terminal N-acetylglucosamine and not of sialic acid or terminal galactose

被引：0
|
作者：
Jones, AJS [1 ]
机构：
[1] Genentech Inc, Analyt Chem, S San Francisco, CA 94080 USA
来源：
GLYCOBIOLOGY | 1999年 / 9卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
76
引用
收藏
页码：1120 / 1120
页数：1
相关论文
共 50 条
  • [1] Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content
    Keck, Rodney
    Nayak, Namita
    Lerner, Laura
    Raju, Shanta
    Ma, Stacey
    Schreitmueller, Thomas
    Chamow, Stephen
    Moorhouse, Kathy
    Kotts, Claire
    Jones, Andrew
    BIOLOGICALS, 2008, 36 (01) : 49 - 60
  • [2] Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys
    Jones, Andrew J. S.
    Papac, Damon I.
    Chin, Edward H.
    Keck, Rodney
    Baughman, Sharon A.
    Lin, Yvonne S.
    Kneer, Johannes
    Battersby, John E.
    GLYCOBIOLOGY, 2007, 17 (05) : 529 - 540
  • [3] TERMINAL N-ACETYLGLUCOSAMINE IN CHRONIC SYNOVITIS
    SHARIF, M
    ROOK, G
    WILKINSON, LS
    WORRALL, JG
    EDWARDS, JCW
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 25 - 31
  • [4] Metabolism of glycoprotein-derived sialic acid and N-acetylglucosamine by Streptococcus oralis
    Homer, KA
    Kelley, S
    Hawkes, J
    Beighton, D
    Grootveld, MC
    MICROBIOLOGY-UK, 1996, 142 : 1221 - 1230
  • [5] Fertilization in mouse does not require terminal galactose or N-acetylglucosamine on the zona pellucida glycans
    Williams, Suzannah A.
    Xia, Lijun
    Cummings, Richard D.
    McEver, Rodger P.
    Stanley, Pamela
    JOURNAL OF CELL SCIENCE, 2007, 120 (08) : 1341 - 1349
  • [6] EXPOSURE OF TERMINAL N-ACETYLGLUCOSAMINE IN CHRONIC SYNOVITIS
    SHARIF, M
    WILKINSON, I
    ROOK, G
    EDWARDS, J
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (04) : 507 - 507
  • [7] Glycoengineering of therapeutic glycoproteins:: In vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues
    Raju, TS
    Briggs, JB
    Chamow, SM
    Winkler, ME
    Jones, AJS
    BIOCHEMISTRY, 2001, 40 (30) : 8868 - 8876
  • [8] A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine
    Bond, A
    Alavi, A
    Axford, JS
    Bourke, BE
    Bruckner, FE
    Kerr, MA
    Maxwell, JD
    Tweed, KJ
    Weldon, MJ
    Youinou, P
    Hay, FC
    JOURNAL OF AUTOIMMUNITY, 1997, 10 (01) : 77 - 85
  • [9] Sialic acid and N-acetylglucosamine Regulate type 1 Fimbriae Synthesis
    Blomfield, Ian C.
    MICROBIOLOGY SPECTRUM, 2015, 3 (03)
  • [10] STRUCTURES OF ASPARAGINE-LINKED OLIGOSACCHARIDES OF THE GLYCOPROTEIN FETUIN HAVING SIALIC-ACID LINKED TO N-ACETYLGLUCOSAMINE
    CUMMING, DA
    HELLERQVIST, CG
    HARRISBRANDTS, M
    MICHNICK, SW
    CARVER, JP
    BENDIAK, B
    BIOCHEMISTRY, 1989, 28 (15) : 6500 - 6512
12345